CVRx, Inc. Long-Term Debt, Maturity, Year Five
CVRx, Inc. (CVRX) had Long-Term Debt, Maturity, Year Five of $41.25 million as of 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2026-05-12
- 2026-03-31: Long-Term Debt, Maturity, Year Five $41.25M.
- 2024-03-31: Long-Term Debt, Maturity, Year Five $10.00M.
- 2023-12-31: Long-Term Debt, Maturity, Year Five $20.00M.
- 2023-09-30: Long-Term Debt, Maturity, Year Five $5.00M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2026-03-31 | $41.25M 10-Q · filed 2026-05-12 |
| 2024-03-31 | $10.00M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $20.00M 10-K · filed 2024-02-09 |
| 2023-09-30 | $5.00M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $5.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |